COLLINGWOOD HEALTH GROUP — All Prescriptions & Medications
Practice Code: A87004 | NORTH SHIELDS, NE29 0SF
Over the last 12 months, COLLINGWOOD HEALTH GROUP prescribed 625,756 items across 784 different medications at a total cost of £4,813,805 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Phosphates (Rectal) | 10 | 40 | £1.1K | -18.2% ▼ |
| Propafenone hydrochloride | 10 | 1,120 | £104 | -7.7% ▼ |
| Nebivolol | 10 | 490 | £97 | -90.6% ▼ |
| Minoxidil | 10 | 462 | £196 | -10.3% ▼ |
| Levofloxacin | 10 | 162 | £167 | +94.0% ▲ |
| Vardenafil | 10 | 56 | £95 | -28.4% ▼ |
| Medroxyprogesterone acetate | 10 | 792 | £745 | +13.3% ▲ |
| Liquid additive lactase (0913121) | 10 | 196 | £224 | +136.5% ▲ |
| Ready to serve 20g protein equivalent (0913205) | 10 | 52.2K | £4.2K | -12.8% ▼ |
| Ketoprofen | 10 | 1,300 | £56 | -72.1% ▼ |
| 10 | 790 | £72 | -16.1% ▼ | |
| 10 | 429 | £1.7K | -45.2% ▼ | |
| 10 | 10 | £214 | +16.4% ▲ | |
| 10 | 600 | £442 | -24.7% ▼ | |
| 10 | 1,550 | £310 | -29.2% ▼ | |
| 10 | 10 | £75 | +61.3% ▲ | |
| 10 | 2,200 | £92 | +11.2% ▲ | |
| 10 | 600 | £2.2K | -24.5% ▼ | |
| 10 | 300 | £37 | -75.3% ▼ | |
| Flupentixol decanoate | 11 | 74 | £249 | -31.1% ▼ |
| Frovatriptan | 11 | 126 | £344 | -22.2% ▼ |
| Canagliflozin | 11 | 1,200 | £1.5K | -92.3% ▼ |
| Hydrocortisone sodium succinate | 11 | 30 | £30 | +188.8% ▲ |
| Clindamycin phosphate | 11 | 440 | £114 | +163.7% ▲ |
| Levonorgestrel | 11 | 2,078 | £53 | +35.3% ▲ |
| Mercaptopurine | 11 | 80 | £35 | -29.0% ▼ |
| Degarelix | 11 | 11 | £1.3K | -36.6% ▼ |
| Sevelamer | 11 | 2,532 | £402 | -49.8% ▼ |
| 11 | 146 | £1.1K | -37.4% ▼ | |
| 11 | 22 | £44 | +104.1% ▲ | |
| 11 | 60 | £587 | -7.6% ▼ | |
| 11 | 22 | £516 | +26.3% ▲ | |
| 11 | 1,100 | £117 | +98.7% ▲ | |
| 11 | 310 | £1.6K | -50.7% ▼ | |
| 11 | 640 | £1.4K | -41.1% ▼ | |
| 11 | 580 | £2.3K | +69.3% ▲ | |
| Olsalazine sodium | 12 | 1,344 | £1.7K | +19.5% ▲ |
| Methyldopa | 12 | 1,344 | £1.4K | -29.5% ▼ |
| Olmesartan medoxomil | 12 | 672 | £29 | -82.6% ▼ |
| Cyproheptadine hydrochloride | 12 | 168 | £33 | +141.5% ▲ |
| Doxepin | 12 | 336 | £1.1K | -7.7% ▼ |
| Rimegepant | 12 | 150 | £1.9K | +22.3% ▲ |
| Galantamine | 12 | 336 | £446 | -68.3% ▼ |
| Avanafil | 12 | 162 | £827 | +91.2% ▲ |
| Enteral nutrition | 12 | 283.0K | £7.9K | +53.5% ▲ |
| Pyridoxine hydrochloride | 12 | 2,688 | £1.1K | -44.2% ▼ |
| Pdr disc/non ACBS protein SfI metabolic condition (0913445) | 12 | 4,800 | £3.2K | +86.2% ▲ |
| Pyridostigmine bromide | 12 | 2,400 | £182 | -29.9% ▼ |
| Diclofenac sodium | 12 | 1,200 | £58 | +12.8% ▲ |
| Hepatitis B | 12 | 12 | £146 | +13.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.